News

JenaValve's Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case ...
European Medical Journal4d
Transcatheter Aortic Valve Implantation in Patients with Pure Non-Calcified Aortic Regurgitation
Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...
European Medical Journal4d
AI-Guided Risk Stratification for Aortic Stenosis using Large Language Models Enhanced with Guidelines
Traditional operative risk calculators, such as the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), ...
MiRus Siegel™ TAVR US Early Feasibility Study (EFS) 30 Day Results Presented at NY Valves Meeting
The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, ...
mayo6d
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation - Mayo Clinic
About this study The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, ...